Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo.
Journal: The Journal of dermatological treatment
Published: September 02, 2026
Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo.
Journal: Journal of managed care & specialty pharmacy
Published: August 18, 2026
The need to integrate spirituality into sleep medicine as a dimension of whole-person, person-centered care.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: June 08, 2026
Clinical Characteristics and Treatment Patterns in Patients With Vitiligo.
Journal: JAMA dermatology
Published: May 06, 2026
Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.
Journal: JAMA dermatology
Published: March 25, 2026
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.
Journal: Lancet (London, England)
Published: March 06, 2026
Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.
Journal: Lancet (London, England)
Published: February 27, 2026
Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.
Journal: Dermatology and therapy
Published: December 15, 2025
Maximizing a Focused Vitiligo Patient Visit: A Practical Approach.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.
Journal: JAMA dermatology
Published: November 26, 2025
Impact of treatment duration on response durability: A post hoc analysis of the double-blind, vehicle-controlled, randomized TRuE-V long-term extension study of ruxolitinib cream in vitiligo.
Journal: Journal of the American Academy of Dermatology
Published: November 13, 2025
Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 07, 2025
Last Updated: 09/26/2026